Medicen Initiative

Time: 8:25 am
day: Day Two


Uncover the benefits of a unity community:
• Regrouping pharmaceutical companies, start-ups and academics in the microbiome field. Actively collecting and understanding the
current, in silico, in vitro and in vivo tools available today and recommend their best potential use
• Explaining the initiative’s aims also, on the basis of use cases in the pharmaceutical industry
• Explore the elaborate decision trees on what triggers microbiome studies today and also what is missing to be able to generate more
systematic microbiome data on future drug products